Northwest Biotherapeutics reported 970K in Ordinary Share Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Agenus AGEN:US $ 2.67M 0.1M
Applied Genetic Technologies AGTC:US $ 0.05M 0.01M
AstraZeneca AZN:LN 387M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0M
Cti Biopharma CTIC:US $ 0.1M 0M
Cytori Therapeutics CYTX:US $ 0.02M 0.01M
Cytrx CYTR:US 43.48K 4.7K
Eisai 4523:JP Y 44986M 0M
Genocea Biosciences GNCA:US $ 0.06M 0M
Infinity Pharmaceuticals INFI:US $ 0.09M 0M
Merk MRK:US $ 1788M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Northwest Biotherapeutics NWBO:US 970K 22K